After a cardiac event, proper treatment and care of the damaged tissue is crucial in restoring optimal cardiac function and preventing future cardiac events. Recently, thymosin β4 has been found to play a vital role in cardiac cell health and development by regulating angiogenesis, inflammatory responses, and wound healing. We proposed that defined poly(ε{lunate}-caprolactone) (PCL) nanoscaffolds coated with thymosin β4 could efficiently differentiate murine-derived cardiomyocytes into functioning cardiac tissue. PCL nanoscaffolds were developed through electrospinning technology, and subsequently coated with a thymosin β4 solution. Cardiomyocytes were seeded on coated and uncoated nanoscaffolds and observed for six days via fluorescent and electron microscopy. Our results demonstrated a robust growth and differentiation of cardiomyocytes on coated nanoscaffolds compared with uncoated, showing potential for nanoscaffold-mediated cardiac cell replacement in vivo after an MI or other cardiac event. © 2014 Kumar et al.; licensee BioMed Central Ltd.
CITATION STYLE
Kumar, A., Patel, A., Duvalsaint, L., Desai, M., & Marks, E. D. (2014). Thymosin β4 coated nanofiber scaffolds for the repair of damaged cardiac tissue. Journal of Nanobiotechnology, 12(1). https://doi.org/10.1186/1477-3155-12-10
Mendeley helps you to discover research relevant for your work.